Mathieu Surenaud
Overview
Explore the profile of Mathieu Surenaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
982
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiedemann A, Surenaud M, Hubert M, Lopez Zaragoza J, Ribeiro A, Rodrigues C, et al.
J Immunol
. 2025 Mar;
214(2):211-222.
PMID: 40073241
The 2022 Mpox virus (MPXV) outbreak revitalized questions about immunity against MPXV and vaccinia-based vaccines (VAC-V), but studies are limited. We analyzed immunity against MPXV in individuals infected with MPXV...
2.
Lalevee S, Surenaud M, Tariq M, Ingen-Housz-Oro S, Jean-Louis F, Barau C, et al.
J Invest Dermatol
. 2025 Feb;
PMID: 39986436
No abstract available.
3.
Abi Zeid Daou Y, Watanabe N, Lidouren F, Bois A, Faucher E, Huet H, et al.
J Am Heart Assoc
. 2024 Aug;
13(16):e035617.
PMID: 39158568
Background: Brain injury is one of the most serious complications after cardiac arrest (CA). To prevent this phenomenon, rapid cooling with total liquid ventilation (TLV) has been proposed in small...
4.
Lacabaratz C, Durand M, Wiedemann A, Foucat E, Surenaud M, Krief C, et al.
J Infect Dis
. 2024 Jul;
231(1):230-240.
PMID: 39012798
Background: The EBL2001 phase 2 trial tested the 2-dose Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine in Europe. Safety and humoral immunogenicity assessments led to European Union market authorization in 2020. Complementary analyses...
5.
Abi Zeid Daou Y, Lidouren F, Bois A, Watanabe N, Jendoubi A, Faucher E, et al.
Intensive Care Med Exp
. 2024 Jul;
12(1):57.
PMID: 38954057
Background: A sepsis-like syndrome is known to occur after cardiac arrest, leading to cerebral infiltration by white blood cells (WBC). We hypothesized that pharmacological sequestration of WBC, and more specifically...
6.
Barry H, Lhomme E, Surenaud M, Nouctara M, Robinson C, Bockstal V, et al.
PLoS Negl Trop Dis
. 2024 Apr;
18(4):e0011500.
PMID: 38603720
Background: The exposure to parasites may influence the immune response to vaccines in endemic African countries. In this study, we aimed to assess the association between helminth exposure to the...
7.
Pastor Y, Reynard O, Iampietro M, Surenaud M, Picard F, El Jahrani N, et al.
Cell Rep Med
. 2024 Mar;
5(3):101467.
PMID: 38471503
Nipah virus (NiV) has been recently ranked by the World Health Organization as being among the top eight emerging pathogens likely to cause major epidemics, whereas no therapeutics or vaccines...
8.
Sawaki D, Zhang Y, Mohamadi A, Pini M, Mezdari Z, Lipskaia L, et al.
JCI Insight
. 2023 Apr;
8(8).
PMID: 37092554
Adipose tissue macrophages (ATMs) play an important role in obesity and inflammation, and they accumulate in adipose tissue (AT) with aging. Furthermore, increased ATM senescence has been shown in obesity-related...
9.
Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19
Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, et al.
J Clin Immunol
. 2023 Mar;
43(5):894.
PMID: 36991251
No abstract available.
10.
Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, et al.
J Clin Immunol
. 2023 Mar;
43(5):882-893.
PMID: 36943669
Purpose: Following a severe COVID-19 infection, a proportion of individuals develop prolonged symptoms. We investigated the immunological dysfunction that underlies the persistence of symptoms months after the resolution of acute...